GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: cytokine Zcyto10 | interleukin-20
                                 
                                                         
                            
                            
                            
                                Compound class: 
                                                            Endogenous peptide in human, mouse or rat
                                 
                                
                                    
                                        Comment: IL-20 is an IL-10 related type II cytokine. The IL-20 pathway is a pharmacological target with potential therapeutic benefit for patients wth rheumatoid arthritis [1].
                                    
                                 
                            
                                
                                    Species: Human
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
| Natural/Endogenous Targets | |||
                                                                     
  | 
                                                            |||
| Selectivity at catalytic receptors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
                                                                        
                                                                         
  | 
                                                                |||||||||||||||||||||||||||||||||||||||||||||||||||||||